Literature DB >> 26346149

Neuroimaging of phakomatoses: overview and advances.

Gilbert Vézina1.   

Abstract

The phakomatoses are disorders characterized by multiple hamartomas and other congenital malformations affecting mainly the skin and the central and peripheral nervous systems. Many affected individuals have an increased genetic susceptibility to develop malignancies. Imaging is central in the diagnosis of many of the phakomatoses, and MRI is used as a screening tool in many children with known neurocutaneous disorders. This manuscript addresses the three most common (neurofibromatosis type 1, tuberous sclerosis complex, Sturge-Weber syndrome) and focuses on pathophysiological and radiologic insights that have emerged in the last few years.

Entities:  

Mesh:

Year:  2015        PMID: 26346149     DOI: 10.1007/s00247-015-3282-3

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  34 in total

1.  Cerebral vasculopathy in children with neurofibromatosis type 1.

Authors:  Partha S Ghosh; A David Rothner; Todd M Emch; Neil R Friedman; Manikum Moodley
Journal:  J Child Neurol       Date:  2012-04-24       Impact factor: 1.987

2.  Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ.

Authors:  Matthew D Shirley; Hao Tang; Carol J Gallione; Joseph D Baugher; Laurence P Frelin; Bernard Cohen; Paula E North; Douglas A Marchuk; Anne M Comi; Jonathan Pevsner
Journal:  N Engl J Med       Date:  2013-05-08       Impact factor: 91.245

3.  MR imaging of the corpus callosum in pediatric patients with neurofibromatosis type 1.

Authors:  E C Dubovsky; T N Booth; G Vezina; C A Samango-Sprouse; K M Palmer; C O Brasseux
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

4.  Comparative analysis of MR sequences to detect structural brain lesions in tuberous sclerosis.

Authors:  Hugo Pereira Pinto Gama; Antônio José da Rocha; Flávio Túlio Braga; Carlos Jorge da Silva; Antonio Carlos Martins Maia; Rogério Gonçalves de Campos Meirelles; José Iram Mendonça do Rego; Henrique Manoel Lederman
Journal:  Pediatr Radiol       Date:  2005-11-11

5.  Neurofibromin regulates neural stem cell proliferation, survival, and astroglial differentiation in vitro and in vivo.

Authors:  Biplab Dasgupta; David H Gutmann
Journal:  J Neurosci       Date:  2005-06-08       Impact factor: 6.167

6.  Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain.

Authors:  D P DiPaolo; R A Zimmerman; L B Rorke; E H Zackai; L T Bilaniuk; A T Yachnis
Journal:  Radiology       Date:  1995-06       Impact factor: 11.105

7.  Spectrum and prevalence of vasculopathy in pediatric neurofibromatosis type 1.

Authors:  Bonnie Kaas; Thierry A G M Huisman; Aylin Tekes; Amanda Bergner; Jaishri O Blakeley; Lori C Jordan
Journal:  J Child Neurol       Date:  2012-07-25       Impact factor: 1.987

8.  MRI characteristics of cerebellar tubers and their longitudinal changes in children with tuberous sclerosis complex.

Authors:  Razan Daghistani; James Rutka; Elysa Widjaja
Journal:  Childs Nerv Syst       Date:  2014-09-09       Impact factor: 1.475

9.  Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012.

Authors:  Jonathan Roth; E Steve Roach; Ute Bartels; Sergiusz Jóźwiak; Mary Kay Koenig; Howard L Weiner; David N Franz; Henry Z Wang
Journal:  Pediatr Neurol       Date:  2013-10-15       Impact factor: 3.372

10.  Alterations in white matter microstructure in neurofibromatosis-1.

Authors:  Katherine H Karlsgodt; Tena Rosser; Evan S Lutkenhoff; Tyrone D Cannon; Alcino Silva; Carrie E Bearden
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

View more
  1 in total

Review 1.  Imaging More than Skin-Deep: Radiologic and Dermatologic Presentations of Systemic Disorders.

Authors:  Mehrzad Shafiei; Firoozeh Shomal Zadeh; Bahar Mansoori; Hunter Pyle; Nnenna Agim; Jorge Hinojosa; Arturo Dominguez; Cristina Thomas; Majid Chalian
Journal:  Diagnostics (Basel)       Date:  2022-08-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.